These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 33657300)

  • 1. Terlipressin and Intravenous Albumin in Advanced Cirrhosis - Friend and Foe.
    Garcia-Tsao G
    N Engl J Med; 2021 Mar; 384(9):869-871. PubMed ID: 33657300
    [No Abstract]   [Full Text] [Related]  

  • 2. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
    Martín-Llahí M; Pépin MN; Guevara M; Díaz F; Torre A; Monescillo A; Soriano G; Terra C; Fábrega E; Arroyo V; Rodés J; Ginès P;
    Gastroenterology; 2008 May; 134(5):1352-9. PubMed ID: 18471512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical curative effect observation of therapy of terlipressin combined with albumin in acute kidney injury with liver cirrhosis].
    Cheng DY; Wan G; Ou WN; Xing HC
    Zhonghua Gan Zang Bing Za Zhi; 2019 Sep; 27(9):704-707. PubMed ID: 31594096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
    Singh V; Kumar R; Nain CK; Singh B; Sharma AK
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):303-7. PubMed ID: 16460491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.
    Boyer TD; Sanyal AJ; Wong F; Frederick RT; Lake JR; O'Leary JG; Ganger D; Jamil K; Pappas SC;
    Gastroenterology; 2016 Jun; 150(7):1579-1589.e2. PubMed ID: 26896734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Response to Terlipressin and albumin is associated with improved outcome in patients with cirrhosis and hepatorenal syndrome].
    Nguyen-Tat M; Götz E; Scholz-Kreisel P; Ahrens J; Sivanathan V; Schattenberg J; Rey JW; Wörns MA; Galle PR; Marquardt JU
    Dtsch Med Wochenschr; 2015 Jan; 140(2):e21-6. PubMed ID: 25612289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study.
    Moreau R; Asselah T; Condat B; de Kerguenec C; Pessione F; Bernard B; Poynard T; Binn M; Grangé JD; Valla D; Lebrec D
    Gut; 2002 Jan; 50(1):90-4. PubMed ID: 11772973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of hepatorenal syndrome in cirrhotic patients with terlipressin plus albumin. First experience in Mexico.
    Muñoz LE; Alcalá EG; Cordero P; Martínez MA; Vázquez NY; Galindo S; Mendoza E; Segura JJ
    Ann Hepatol; 2009; 8(3):207-11. PubMed ID: 19841499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome.
    Nazar A; Pereira GH; Guevara M; Martín-Llahi M; Pepin MN; Marinelli M; Solá E; Baccaro ME; Terra C; Arroyo V; Ginès P
    Hepatology; 2010 Jan; 51(1):219-26. PubMed ID: 19877168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.
    Ortega R; Ginès P; Uriz J; Cárdenas A; Calahorra B; De Las Heras D; Guevara M; Bataller R; Jiménez W; Arroyo V; Rodés J
    Hepatology; 2002 Oct; 36(4 Pt 1):941-8. PubMed ID: 12297842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of terlipressin and somatostatin on liver and thorax blood volumes in patients with cirrhosis.
    Kalambokis G; Tsiouris S; Tsianos EV; Baltayiannis G; Pakou B; Fotopoulos A
    Liver Int; 2010 Oct; 30(9):1371-8. PubMed ID: 20738780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of terlipressin in cirrhotic patients with refractory ascites and normal renal function: a multicentric study.
    Fimiani B; Guardia DD; Puoti C; D'Adamo G; Cioffi O; Pagano A; Tagliamonte MR; Izzi A
    Eur J Intern Med; 2011 Dec; 22(6):587-90. PubMed ID: 22075285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Observation of the therapeutic and characteristic effects of terlipressin on refractory cirrhotic ascites].
    Xing F; Li S; Zhang JJ; Sun CY; Huang JR; Gao ZL; Zhu TT; Zhao Q; Zhang H; Liu CH
    Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):982-988. PubMed ID: 31941260
    [No Abstract]   [Full Text] [Related]  

  • 14. [When should we give albumin in patients with cirrhosis?].
    Bochatay L; Elkrief L; Spahr L
    Rev Med Suisse; 2015 Sep; 11(484):1596, 1598-601. PubMed ID: 26502620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Treatment of Hepatorenal Syndrome.
    Cavallin M; Fasolato S; Marenco S; Piano S; Tonon M; Angeli P
    Dig Dis; 2015; 33(4):548-54. PubMed ID: 26159272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review with meta-analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1.
    Gifford FJ; Morling JR; Fallowfield JA
    Aliment Pharmacol Ther; 2017 Mar; 45(5):593-603. PubMed ID: 28052382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis.
    Narahara Y; Kanazawa H; Taki Y; Kimura Y; Atsukawa M; Katakura T; Kidokoro H; Harimoto H; Fukuda T; Matsushita Y; Nakatsuka K; Sakamoto C
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1791-7. PubMed ID: 19686420
    [TBL] [Abstract][Full Text] [Related]  

  • 18.  Hepatorenal syndrome: Current concepts related to diagnosis and management.
    de Mattos ÁZ; de Mattos AA; Méndez-Sánchez N
    Ann Hepatol; 2016; 15(4):474-81. PubMed ID: 27236146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic effects of a combination of octreotide and terlipressin in patients with viral hepatitis related cirrhosis.
    Lin HC; Yang YY; Hou MC; Huang YT; Lee WC; Lee FY; Chang FY; Lee SD
    Scand J Gastroenterol; 2002 Apr; 37(4):482-7. PubMed ID: 11989841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research progress of terlipressin in the treatment of cirrhotic ascites-related complications].
    Liu CH; Xing F; Wang J
    Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):929-932. PubMed ID: 31941255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.